Table 1 Univariate and multivariate analysis of factors influencing DSS in 7156 PDAC patients with single-organ metastasis.

From: Surgery for synchronous and metachronous single-organ metastasis of pancreatic cancer: a SEER database analysis and systematic literature review

Variable

 

N

1-year survival

rate

2-year survival rate

3-year survival rate

Median survival  ± SE (M)

Univariate analysis

Multivariate analysis

95% CI

p value

HR

95% CI

p value

Single-organ metastasis

 

7156

16.95%

5.09%

1.95%

4.0  ± 0.08

3.84–4.16

    

Gender

female

3296

16.74%

5.28%

1.82%

4.0 ± 0.12

3.77–4.23

>0.05

   

male

3860

17.11%

4.93%

2.00%

4.0 ± 0.11

3.78–4.22

  

Age

20–44 years

190

30.51%

8.49%

NA

8.0 ± 0.88

6.28–9.17

<0.0001

(20–64 years/65+ years)

1:1.24

(20–64 years/65+ years)

1.16–1.36

<0.0001

45–64 years

3082

20.90%

6.82%

2.65%

5.0 ± 0.15

4.72–5.28

65–74 years

2231

16.84%

4.36%

NA

4.0 ± 0.14

3.72–4.28

75+ years

1653

8.09%

2.43%

NA

3.0 ± 0.10

2.80–3.20

Localization

head

2829

21.26%

5.24%

2.27%

5.0 ± 0.14

4.72–5.28

0.015

(head/body and tail)

  

>0.05

body-tail

2496

19.44%

4.80%

1.73%

4.0 ± 0.14

3.72–4.28

unknown

1831

NA

NA

NA

NA

     

Differentiation

G1, G2

790

22.27%

8.15%

1.82%

6.0 ± 0.31

5.39–6.61

<0.0001

(G1-2/G3-4)

1:1.31

(G1-2/G3-4)

1.17–1.50

<0.0001

G3, G4

841

13.41%

3.54%

NA

4.0 ± 0.20

3.61–4.39

unknown

5524

NA

NA

NA

NA

     

T classification

T4

1376

17.35%

4.59%

NA

5.0 ± 0.11

4.79–5.21

>0.05

   

T1-T3

4139

18.73%

5.85%

2.10%

5.0 ± 0.20

4.60–5.40

 

unknown

1641

NA

NA

NA

NA

   

Metastatic site

liver

6252

13.87%

2.99%

0.6%

4.0 ± 0.09

3.83–4.17

<0.0001

(others/lung)

1:0.87

(others/lung)

0.78–0.97

0.013

lung

740

19.46%

4.60%

0.67%

6.0 ± 0.32

5.37–6.63

bone

147

17.00%

NA

NA

6.0 ± 0.99

4.05–7.94

brain

17

0

0

0

4.0 ± 0.08

2.67–5.33

  1. NA: not available.